Pages that link to "Q38291123"

The following pages link to Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations (Q38291123):

Displaying 9 items.

• Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. (Q26827810) (← links)
• p73 in Cancer. (Q35103143) (← links)
• N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy (Q36055168) (← links)
• Mechanisms, function and clinical applications of DNp73. (Q37075900) (← links)
• The TP73 complex network: ready for clinical translation in cancer? (Q38126476) (← links)
• Alterations of p63 and p73 in human cancers (Q38247152) (← links)
• A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression (Q38266299) (← links)
• Clinical implications of the deregulated TP73 isoforms expression in cancer. (Q48136784) (← links)
• Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk. (Q64927399) (← links)